In a 2018 analysis of clinical trial data, several researchers working with Novo Nordisk, the drugmaker for Ozempic and Wegovy, found that the drugs were safe and effective in adults over age 65, but noted that older adults reported discontinuation due to gastrointestinal issues at a higher rate than younger participants did
Given the widespread and increasing use of these medications and the urgency of providing advice to individuals using the drugs, as well as calling for more research the researchers argue that we can turn to what has been learnt from the guidance and support offered alongside weight loss surgery, such as gastric bands, which leads to similar outcomes to GLP-1 drugs
Free Radical Biol Med 1(87):14 Orian L et al (2018) The catalytic mechanism of glutathione peroxidases in Glutathione
UnitedHealthcare (UHC) is a huge companythe largest insurer in the U.S
Excess body weight, particularly after menopause, is a well-established risk factor for breast cancer
While semaglutide offers weight loss benefits, it also carries a potential risk of hair loss